Biohaven Pharmaceutical Holding

BHVN

Held by 2 specialist biotech funds

Share on X

Fund Holdings

Redmile Group

Eventide Asset Management

Position history (shares)

Redmile Group

2Q

Eventide Asset Management

2Q

2 quarters

Position Trend

Aug 14, 2025

$14.5M

2 funds

Nov 14, 2025

$0

0 funds

Feb 13, 2026

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 5 quarters

Short Interest

Short Shares

21.90M

Change

+1.8%

Days to Cover

9.9

% of Float

18.6%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Activist Filings

SC 13G/ARA Capital Management0.0%Feb 14, 2019

Position Details

Redmile GroupEXITFeb 17, 2026

Shares: 0Value: N/A

Eventide Asset ManagementEXITFeb 13, 2026

Shares: 0Value: N/A

+ 6more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CLDX2 funds ORIC2 funds IVVD2 funds NRIX2 funds SRRK2 funds ADCT2 funds AKRO2 funds IDYA2 funds

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: